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Several groups have reported that the cardiac Na ϩ /Ca 2ϩ exchange protein is phosphorylated by PKA (16, 26, 27, 30) .
The augmentation of exchange activity through the ␤-adrenergic signaling pathway has also been reported. Linck et al. (19) found that Na ϩ -dependent Ca 2ϩ uptake of baby hamster kidney (BHK) cells expressing canine cardiac Na ϩ /Ca 2ϩ exchanger 1 (NCX1) was enhanced by 100 M forskolin, an activator of adenylate cyclase, by ϳ20%. In whole cell voltage-clamped guinea pig ventricular myocytes with other major currents inhibited, Perchenet et al. (25) and Zhang et al. (33) demonstrated that ␤-adrenergic stimulation enhanced Na ϩ / Ca 2ϩ exchange current (I NCX ) by ϳ25-100%. Ruknudin et al. (26) found that PKA-activating reagents phosphorylated a cardiac isoform of the NCX expressed in Xenopus oocytes and increased both 45 Ca 2ϩ uptake (by ϳ40%) and outward I NCX (by Ͼ100%). They also observed PKA-dependent enhancement of Na ϩ -dependent 45 Ca 2ϩ uptake by ϳ40% in adult rat ventricular cardiomyocytes. Wei at al. (30) also reported that PKA phosphorylated the Na ϩ /Ca 2ϩ exchange protein and increased I NCX by ϳ500% in control and by ϳ100% in failing ventricular cells from pig heart, suggesting that cardiac Na ϩ / Ca 2ϩ exchange is hyperphosphorylated in heart failure. To the contrary, no stimulatory effect of ␤-adrenergic receptor stimulation or PKA on exchange activity was detected in giant membrane patches excised from blebs of guinea pig ventricular cells (5) , vesicle preparations of rat hearts (2), guinea pig ventricular cells (20) , or BHK cells expressing the dog cardiac NCX1 (13) .
The aim of this study was to clarify the effect of ␤-adrenergic stimulation on the native mammalian NCX. We measured I NCX in voltage-clamped ventricular myocytes isolated from guinea pig, mouse, and rat hearts and studied the effect of ␤-adrenergic stimulation, with particular attention to the contribution of the PKA-activated Cl Ϫ current (CFTR-Cl Ϫ current, I CFTR-Cl ) to the recorded membrane current. We concluded that ␤-adrenergic stimulation does not significantly affect I NCX in the ventricular cells. When I NCX was recorded using a protocol similar to the previous study using Ni 2ϩ (25, 30, 33) , a nonselective blocker of the exchanger, the amplitude of Ni 2ϩ -sensitive membrane current apparently increased after the application of isoproterenol, suggesting an increase in I NCX . However, this potentiation was in fact attributable to an increase in I CFTR-Cl contaminating the Ni 2ϩ -sensitive current. Part of this study was presented at the 48th annual meeting of the Biophysical Society (31) .
METHODS
Cell isolation. Ventricular myocytes were dissociated from guinea pig, mouse, and rat hearts. All procedures were approved by the Animal Research Committee of the Graduate School of Medicine, Kyoto University. The animals were deeply anesthetized by intraperitoneal injection of pentobarbital sodium (Ͼ0.1 mg/g body wt). For guinea pig hearts, the thorax was opened under artificial respiration and the aorta was cannulated to start retrograde perfusion of the heart. The heart was quickly excised and mounted on a Langendorff-type perfusion apparatus. The heart was first perfused with a control Tyrode solution and then with a nominally Ca 2ϩ -free control Tyrode solution until the heartbeat stopped, followed by Ca 2ϩ -free Tyrode solution containing 0.4 mg/ml collagenase (type I; Worthington Biochemical) for ϳ15 min. Finally, the perfusate was switched to a high-K ϩ , low-Cl Ϫ solution. The left ventricle and the septum were diced into ϳ10 pieces and shaken gently in the high-K ϩ , low-Cl Ϫ solution for ϳ5 min. After filtration of the dispersed tissues, the resulting cell suspension was centrifuged (300 rpm, 5 min) and suspended in a modified DMEM solution.
Mouse and rat hearts were perfused with a cell isolation solution containing collagenase (type II, 1 mg/ml; Worthington Biochemical), trypsin (type I, 0.05 mg/ml; Sigma), protease (type XIV, 0.05 mg/ml; Sigma), and 0.2 mM CaCl 2 for 10 min. The left ventricle and the septum were then diced and shaken gently for ϳ15 min in the cell isolation solution noted above with BSA (fraction V, 1 mg/ml; Sigma). After filtration, the cell suspension was centrifuged and resuspended in the modified DMEM solution. The myocytes were used for experiments within 8 h.
Electrophysiology. The myocytes were voltage clamped using the whole cell voltage-clamp method with an Axopatch 200B amplifier (Axon Instruments). Current-voltage (I-V) relationships were measured by applying ramp pulses (change in voltage with time ϭ 680 mV/s) as described in our previous study (10) . Membrane current was filtered at 1 kHz and digitized at 2 kHz with a 12-bit analog-to-digital converter (ADM 670PCI; Micro Science, Tokyo, Japan), which was controlled using our original software. The ramp voltage pulse was applied every 2 or 6 s as indicated. The holding potential was Ϫ40 mV, and the experimental temperature was 36 -37°C.
Solutions. The control Tyrode solution contained (in mM) 140 NaCl, 5.4 KCl, 1.8 CaCl 2, 0.5 MgCl2, 0.3 NaH2PO4, 5.5 glucose, and 5.0 HEPES (pH 7.4 with NaOH). The high-K ϩ , low-Cl Ϫ solution contained (in mM) 25 KCl, 70 K ϩ -glutamate, 10 KH2PO4, 10 taurine, 0.5 EGTA, 11 glucose, and 10 HEPES (pH 7.3 with KOH). The modified DMEM solution was prepared by adding 20 mM NaCl and 25 mM HEPES to DMEM (without NaHCO 3; ICN Biomedicals), and pH was adjusted to 7.4 with NaOH. The cell isolation solution for mouse and rat myocytes contained (in mM) 130 NaCl, 5.4 KCl, 0.5 MgCl 2, 0.33 NaH2PO4, 25 HEPES, 22 glucose, 1 L-glutamine, and 0.1 EGTA with 0.01 U/ml insulin (pH 7.4 with NaOH).
To record I NCX or ICFTR-Cl, K ϩ channels, Ca 2ϩ channels and Na ϩ -K ϩ pump were inhibited using tetraethylammonium, Cs ϩ , Ba 2ϩ , nicardipine, and ouabain in a manner similar to methods described in previous studies (10, 22) . The compositions of bath and pipette solutions are listed in Table 1 . The ␤-adrenergic receptor signaling cascade was activated by adding 1 M isoproterenol or 10 M forskolin to the bath.
In particular, when recording I CFTR-Cl (see Fig. 1 Statistical analysis. Membrane current was normalized by cell capacitance (pA/pF) and presented as mean (SD). Statistical analysis was performed using one-way repeated-measures ANOVA with the Student-Newman-Keuls test (StatView, SAS Institute). P Ͻ 0.05 was considered significant.
RESULTS

Inhibition of isoproterenol-activated I CFTR-Cl by Ni
2ϩ . In guinea pig ventricular myocytes, ␤-adrenergic stimulation activates I CFTR-Cl , whose I-V relationship is similar to that for I NCX (1, 12, 21) . However, in the previous reports studying the effects of ␤-adrenergic stimulation on I NCX in intact myocytes, activation of I CFTR-Cl was not systematically investigated. In this study, we first tested whether Ni 2ϩ , which has often been Fig. 1A , I CFTR-Cl was activated by applying 1 M isoproterenol, and membrane currents at ϩ50 and Ϫ100 mV were plotted against time. The I-V relationship of the isoproterenol-activated current (the difference between b and a in Fig. 1B) showed characteristics of I CFTR-Cl , and the reversal potential [Ϫ34 mV (SD 6) (n ϭ 7)] was close to the calculated equilibrium potential of Cl Ϫ (Ϫ33 mV). Under these experimental conditions, I NCX was effectively inhibited by removing Na ϩ and Ca 2ϩ from the pipette solution (addition of 10 mM EGTA) and by omitting Ca 2ϩ from the extracellular solution. Inhibition of I NCX was confirmed by the finding that 5 mM Ni 2ϩ did not attenuate membrane current in the absence of isoproterenol (n ϭ 3, data not shown). In contrast, superfusion of 5 mM Ni 2ϩ almost completely and reversibly inhibited I CFTR-Cl induced by isoproterenol. The half-maximal concentration of Ni 2ϩ required to inhibit I CFTR-Cl was 0.5 mM (Fig. 1C) .
It is notable that Ni 2ϩ exerted an inhibitory action after a time lag (ϳ30 s), whereas no delay was observed upon removing Ni 2ϩ (see also Fig. 3A ). This fact suggests that the Ni 2ϩ action was not due to the competition with Cl Ϫ at the channel pore. Indeed, 5 mM (as shown in Fig. 1D ; n ϭ 4) or 10 mM Ni 2ϩ (n ϭ 4) did not attenuate I CFTR-Cl , which is induced by forskolin, an activator of adenylate cyclase. Therefore, we concluded that the site of Ni 2ϩ action is upstream of adenylate cyclase in the ␤-adrenergic signaling cascade, perhaps at the ␤-adrenergic receptor or related G protein (G s ). The above experimental findings suggest that if I NCX is isolated as the Ni 2ϩ -sensitive current, then I NCX is overestimated during ␤-adrenergic stimulation because of contamination of I CFTR-Cl .
Potentiation of Ni 2ϩ -sensitive current by isoproterenol. The effect of ␤-adrenergic stimulation on I NCX was studied with a protocol similar to previous studies by applying 5 mM Ni 2ϩ (25, 30, 33) as shown in Fig. 2 . Application of 5 mM Ni 2ϩ rapidly and reversibly inhibited I NCX under control conditions. One micromolar isoproterenol increased the membrane conductance such that the amplitude of five millimolar Ni 2ϩ -sensitive current was larger by 77% in the presence of isoproterenol (d Ϫ e in Fig. 2B ) than in control (a Ϫ b in Fig. 2B ). No significant difference was observed between the reversal potential of the Ni 2ϩ -sensitive current before and during isoproterenol application. In 29 cells, the degree of isoproterenol activation of the Ni 2ϩ -sensitive current ranged from Ϫ5% to 135% [32% (SD 35)], consistent with previous reports (25, 33) . However, it should be noted that Ni 2ϩ inhibition in the presence of isoproterenol has both rapid and delayed components in the majority of cells, whereas only the rapid effect is apparent in the control (Fig. 2A) .
The time course of the Ni 2ϩ action is summarized in Fig. 3 . The inhibition of I CFTR-Cl by Ni 2ϩ (Fig. 3A) was characterized by a time lag of ϳ30 s on average, and the inhibition time course was variable among cells. No time lag was apparent in the inhibition of I NCX by Ni 2ϩ in the absence of isoproterenol (Fig. 3B) . During ␤-adrenergic stimulation induced by 1 M isoproterenol, Ni 2ϩ rapidly attenuated the membrane current in a manner similar to that of control, followed by a plateau and further inhibition in 19 of 29 cells. The duration of the plateau was close to the observed time lag of Ni 2ϩ inhibition of I CFTR-Cl . The delayed component was not clear in the other 10 cells. The amplitude of Ni 2ϩ -sensitive current during isoproterenol application was significantly larger than that of the control in the group with the delayed component [by 47.4% (SD 35.3); n ϭ 19] but not in the group without the delayed component (Fig. 3D) . In the latter case, longer application might be needed to reach a full Ni 2ϩ inhibition. The delayed To decrease the possible contamination of I NCX by I CFTR-Cl , we carried out the same protocol using a lower-Cl Ϫ bath solution (bath solution 3) and measured the amplitude of I NCX at a membrane potential near the reversal potential for I CFTR-Cl (Fig. 4) . One micromolar isoproterenol did not affect membrane current at ϩ50 mV but increased it at Ϫ100 mV ( Fig. 4B ) [Ϫ45 mV (SD 3.9); n ϭ 14]. The amplitude of the Ni 2ϩ -sensitive current during isoproterenol application was not significantly different from that in control, when the amplitude was measured at ϩ50 mV (Fig. 4C) . The amplitude of the Ni 2ϩ -sensitive current measured at Ϫ100 mV tended to be larger in the presence of isoproterenol than that in the control. However, the difference was not statistically significant (data not shown), although isoproterenol significantly increased the membrane current amplitude at Ϫ100 mV by 90% (SD 60) (n ϭ 14). The Ni 2ϩ inhibition of isoproterenol action might be weaker under the experimental condition of low extracellular Cl Ϫ . The effect of ␤-adrenergic stimulation on I NCX was studied further with forskolin (Fig. 5) . Because forskolin-activated I CFTR-Cl was not attenuated by Ni 2ϩ (Fig. 1D) , the contamination of I CFTR-Cl in the recorded Ni 2ϩ -sensitive I NCX should be negligible when adenylate cyclase is activated by forskolin. Ten micromolar forskolin increased membrane conductance, probably because of activation of I CFTR-Cl (Fig. 5A) . However, the I-V relationship of Ni 2ϩ -sensitive I NCX during forskolin application was almost identical to control (Fig. 5B) , and no statistical significance was found between the amplitude of the Ni 2ϩ -sensitive current before and during forskolin application (Fig. 5C) .
No potentiation of I NCX by isoproterenol. The above findings indicated that ␤-adrenergic receptor stimulation does not increase I NCX . However, Ni 2ϩ has multiple nonspecific effects and could conceivably interfere with the detection of an underlying ␤-adrenergic activation of I NCX . To rule out this possibility, I NCX was isolated as an extracellular Ca 2ϩ -activated current as previously described (6, 22) instead of using Ni 2ϩ (Fig. 6 ). Figure 6A shows 0.5 mM Ca 2ϩ -induced outward I NCX at a holding potential of Ϫ40 mV. One micromolar isoproterenol induced an inward shift of the holding current and increased membrane conductance due to activation of I CFTR-Cl . It should be noted that I NCX (b Ϫ a, Fig. 6A ) was outward at the membrane potentials examined because of a higher Na ϩ concentration in the pipette solution and was clearly different from I CFTR-Cl (c Ϫ a, Fig. 6A ). Isoproterenol did not change I NCX (d Ϫ c, Fig. 6A ). Figure 6B shows the time courses of Ca 2ϩ -induced I NCX and membrane current in the absence of extracellular Ca 2ϩ , which reflects I CFTR-Cl . I NCX at the end of isoproterenol application tended to be smaller than the control [95.2% (SD 13.7) of control, n ϭ 10], but the difference was not statistically significant (Fig. 6C) . We conclude from this and the above-described experiments that ␤-adrenergic stimulation does not significantly affect I NCX in guinea pig ventricular myocytes.
The effect of ␤-adrenergic stimulation on I NCX was studied further in murine and rat ventricular myocytes using the same protocol as described in Fig. 6 and as shown in Fig. 7 . In these ventricular cells, 1 M isoproterenol did not activate I CFTR-Cl , consistent with the results in previous studies (18, 24) . No significant difference was found between the amplitude of I NCX before and during isoproterenol application in either murine or rat myocytes. We concluded that ␤-adrenergic stimulation has no significant effect on I NCX in guinea pig, mouse, or rat ventricular cells.
DISCUSSION
We studied the effect of ␤-adrenergic stimulation on I NCX in voltage-clamped guinea pig, mouse, and rat ventricular cells. No significant activation of I NCX by ␤-adrenergic stimulation was detected. When I NCX was defined as Ni 2ϩ -sensitive current in guinea pig ventricular myocytes, it was apparently increased by isoproterenol. However, this augmentation was most likely due to the activation of I CFTR-Cl , which is also sensitive to Ni 2ϩ . Our results support previous studies (2, 5, 13, 20) and a recent report of studies of rabbit ventricular cells by Ginsburg and Bers (11) . Using guinea pig ventricular cells, Perchenet et al. (25) and Zhang et al. (33) reported the enhancement of I NCX by ␤-adrenergic stimulation. We were able to confirm their experimental results using a similar experimental protocol with Ni 2ϩ (Fig. 2) . However, the apparent enhancement of I NCX was probably due to the activation of I CFTR-Cl in light of the following findings. Fig. 1 ) suggests that I CFTR-Cl was suppressed by Ni 2ϩ in their experiments. They ruled out the involvement of I CFTR-Cl in their study, because 9-anthracenecarboxylic acid and glibenclamide did not affect the increases in I NCX (25) . However, the dose of the blockers and the experimental protocols were not clearly stated in their study. We did not study these blockers in the present study, because Ni 2ϩ clearly attenuated the activation of I CFTR-Cl by isoproterenol. One difference between our study and that of Perchenet et al. (25) is the effect of forskolin on I NCX . Although they found an enhancement of Ni 2ϩ -sensitive I NCX by forskolin, we failed to detect this. The reason for this discrepancy is not yet clear. However, our finding is consistent with the view that the apparent activation of I NCX was due to the contamination of I CFTR-Cl , because I CFTR-Cl activated by forskolin was not attenuated by Ni 2ϩ (Fig. 1D ). Wei et al. (30) reported that isoproterenol enhanced I NCX (5 mM Ni 2ϩ -sensitive current) in pig heart by ϳ500%. If I CFTR-Cl is also activated by ␤-adrenergic stimulation in pig ventricular cells, the increase in I NCX is likely to be overestimated. In mouse and rat ventricular myocytes, we could not detect significant effects of isoproterenol on I NCX and isoproterenol did not activate a membrane current similar to I CFTR-Cl . The lack of isoproterenol-activated Cl Ϫ current in mouse and rat ventricular cells is consistent with previous reports (18, 24) . In these myocytes, agonists to purinergic receptors activate the Cl Ϫ current (17, 29, 32) . The cardiac Na ϩ /Ca 2ϩ exchange protein may indeed be phosphorylated by PKA (16, 26, 27) , and its activity may be enhanced by PKA in heterogeneous expression systems (19, 26) . However, the enhancement might be due to secondary modulation of Na ϩ -or Ca 2ϩ -dependent regulation (14, 15) because intracellular Na ϩ and Ca 2ϩ were not tightly controlled in these experiments. Further study is needed to clarify the differences between the results in heterogeneous expression systems and those in native cells. To the contrary, the current through the amphibian cardiac NCX, which has a potential nucleotide-binding site (a Walker A motif), seems to be attenuated by the activation of the ␤-adrenergic receptor (7, 13) . Ni 2ϩ appears to act upstream of adenylate cyclase in the ␤-adrenergic signaling pathway. We (21, 23) . The underlying mechanisms of Ni 2ϩ action and the removal of extracellular Na ϩ in ␤-adrenergic signaling may be similar, although the precise mechanism is not clear at present.
